|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/28 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3229828 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15808177.8 |
| Date of filing the European patent application | 2015-12-10 | |
| (97) | Date of publication of the European application | 2017-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-05 |
| (46) | Date of publication of the claims translation | 2023-06-12 |
| (86) | Number | PCT/EP2015/079285 |
| Date | 2015-12-10 |
| (87) | Number | WO 2016/092026 |
| Date | 2016-06-16 |
| (30) | Number | Date | Country code |
| 14197685 | 2014-12-12 | EP | |
| 15193940 | 2015-11-10 | EP |
| (72) |
SOUHAMI, Elisabeth , FR
SILVESTRE, Louise , FR
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Insulino glargino/liksisenatido fiksuoto santykio kompozicija |
| INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2025-10-23 | 11 | 289.00 EUR |
| 2026-12-10 |